Zimmer Biomet Holdings Inc Market Cap ($18.53 Billion)
Market Cap & Net Worth: Zimmer Biomet Holdings Inc (ZBH)
Zimmer Biomet Holdings Inc market cap. Zimmer Biomet Holdings Inc (NYSE:ZBH) has a market capitalization of $18.53 Billion ($18.53 Billion) as of November 1, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1331 globally and #547 in its home market, demonstrating a -4.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zimmer Biomet Holdings Inc's stock price $94.52 by its total outstanding shares 198181555 (198.18 Million). Also see ZBH cash flow metrics for how efficiently the company converts equity into cash flow.
Zimmer Biomet Holdings Inc Market Cap History (2015–2026)
Zimmer Biomet Holdings Inc market cap history from 2015 to 2026. Data shows growth from $18.41 Billion to $18.73 Billion (0.58% CAGR). Check ZBH stock price and chart for real-time trading data and today's change.
Index Memberships
Zimmer Biomet Holdings Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.47 Trillion | 0.05% | #377 of 503 |
Weight: Zimmer Biomet Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Zimmer Biomet Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zimmer Biomet Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Zimmer Biomet Holdings Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.73x
Zimmer Biomet Holdings Inc's market cap is 2.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.16x
Zimmer Biomet Holdings Inc's market cap is 23.16 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $18.41 Billion | $6.00 Billion | $147.00 Million | 3.07x | 125.20x |
| 2016 | $18.67 Billion | $7.67 Billion | $305.90 Million | 2.44x | 61.05x |
| 2017 | $22.01 Billion | $7.80 Billion | $1.81 Billion | 2.82x | 12.13x |
| 2018 | $19.08 Billion | $7.93 Billion | -$379.20 Million | 2.41x | N/A |
| 2019 | $27.74 Billion | $7.98 Billion | $1.13 Billion | 3.48x | 24.51x |
| 2020 | $28.78 Billion | $6.13 Billion | -$138.90 Million | 4.70x | N/A |
| 2021 | $23.88 Billion | $6.83 Billion | $401.60 Million | 3.50x | 59.47x |
| 2022 | $24.92 Billion | $6.94 Billion | $231.40 Million | 3.59x | 107.67x |
| 2023 | $23.97 Billion | $7.39 Billion | $1.02 Billion | 3.24x | 23.41x |
| 2024 | $20.93 Billion | $7.68 Billion | $903.80 Million | 2.73x | 23.16x |
Competitor Companies of ZBH by Market Capitalization
Companies near Zimmer Biomet Holdings Inc in the global market cap rankings as of November 1, 2026. Also see Zimmer Biomet Holdings Inc total assets for a full breakdown of the balance sheet.
Key companies related to Zimmer Biomet Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Zimmer Biomet Holdings Inc (2015–2026)
Market capitalization of Zimmer Biomet Holdings Inc from 2015 to today. Between 2015 and today, Zimmer Biomet Holdings Inc's market cap moved from $18.41 Billion to $ 18.73 Billion, with a yearly change of 0.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $18.73 Billion | +5.12% |
| 2025 | $17.82 Billion | -14.87% |
| 2024 | $20.93 Billion | -12.65% |
| 2023 | $23.97 Billion | -3.81% |
| 2022 | $24.92 Billion | +4.32% |
| 2021 | $23.88 Billion | -17.02% |
| 2020 | $28.78 Billion | +3.77% |
| 2019 | $27.74 Billion | +45.37% |
| 2018 | $19.08 Billion | -13.30% |
| 2017 | $22.01 Billion | +17.86% |
| 2016 | $18.67 Billion | +1.46% |
| 2015 | $18.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Zimmer Biomet Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.53 Billion USD |
| MoneyControl | $18.53 Billion USD |
| MarketWatch | $18.53 Billion USD |
| marketcap.company | $18.53 Billion USD |
| Reuters | $18.53 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more